Hilfe
Feedback
Suche

Medical Technology Development and Commercialization




Preis:
12.95 EUR*
(inkl. MWST zzgl. Versand - Preis kann jetzt höher sein!)
Versand:0.00 EUR Versandkostenfrei innerhalb von Deutschland
Partner:buecher.de
Hersteller:Forgotten Books (Author, Unknown)
Stand:2015-08-04 03:50:33

Auf meinen Wunschzettel Partnerseite besuchen

Produktbeschreibung

Excerpt from Medical Technology Development and Commercialization: Hearing Before the Subcommittee on Technology of the Committee on Science, U. S. House of Representatives, One Hundred Fourth Congress, First Session, November 2, 1995 The subcommittee met, pursuant to notice, at 9:10 a.m., in Room 2318, Rayburn House Office Building, Hon. Constance A. Morelia [chairwoman of the subcommittee] presiding. Present: Representatives Morelia, Calvert, Gutknecht, Seastrand, Tanner, Johnson, McCarthy, and Lofgren. Also present: Representative Walker. Staff present: Mike Quear, professional staff, and Farrell Corley, professional staff. Mrs. Morella. The hearing of the Subcommittee on Technology will now come to order. Good morning. This is the second in a series of oversight hearings the Technology Subcommittee has been holding regarding the effect of tax, antitrust legislation, and other legal and governmental policies and their impact on our Nation´s high technology companies. The impact of these factors are very important since the successful promotion of technology and competitiveness are significant determinants of our sustainable economic growth, productivity, and competitive standing. In this hearing we´re going to discuss the impact of these factors specifically upon one of our Nation´s most important and competitive industries, medical technologies. Research and development of medical technologies is literally a matter of life and death. Advances in medical technologies are crucial, not only for our Nation´s biotechnology and medical device companies, but also for the billions of people around the world who wait and hope for cures for major illnesses. Delays in getting new drugs to market are not only economic, but also result in human suffering and potential loss of lives. Despite this recognized need for the continual advancement of medical development and innovations, I and many of my colleagues keep hearing our Nation´s medical technology companies call for major overhaul of regulations and policies which hinder the creation and commercialization of new technologies. About the Publisher Forgotten Books publishes hundreds of thousands of rare and classic books. Find more at www.forgottenbooks.com This book is a reproduction of an important historical work. Forgotten Books uses state-of-the-art technology to digitally reconstruct the work, preserving the original format whilst repairing imperfections present in the aged copy. In rare cases, an imperfection in the original, such as a blemish or missing page, may be replicated in our edition. We do, however, repair the vast majority of imperfections successfully; any imperfections that remain are intentionally left to preserve the state of such historical works.


Weitere Informationen und der aktuelle Preis im Shop von buecher.de | Dieses Produkt auf den Wunschzettel legen
* Preis kann jetzt höher sein. Den aktuellen Stand und Informationen zu den Versandkosten finden sie auf der Homepage unseres Partners.

Folgende Produkte könnten dir ebenso gefallen